These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7438681)

  • 1. Influence of prolonged recumbency on drug disposition.
    Kates RE; Harapat SR; Keefe DL; Goldwater D; Harrison DC
    Clin Pharmacol Ther; 1980 Nov; 28(5):624-8. PubMed ID: 7438681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic principles of lidocaine dosing in relation to disease state.
    Waller ES
    J Clin Pharmacol; 1981 Apr; 21(4):181-94. PubMed ID: 7240439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of drugs in the elderly.
    Lee EJ
    Ann Acad Med Singap; 1987 Jan; 16(1):128-32. PubMed ID: 2884923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine disposition--sex differences and effects of cimetidine.
    Wing LM; Miners JO; Birkett DJ; Foenander T; Lillywhite K; Wanwimolruk S
    Clin Pharmacol Ther; 1984 May; 35(5):695-701. PubMed ID: 6713782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic changes in old age: relation to altered drug disposition.
    Greenblatt DJ; Divoll M; Abernethy DR; Shader RI
    J Am Geriatr Soc; 1982 Nov; 30(11 Suppl):S6-10. PubMed ID: 7130589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of posture on the pharmacokinetics of intravenous benzylpenicillin.
    Rumble RH; Roberts MS; Scott AR
    Eur J Clin Pharmacol; 1986; 30(6):731-4. PubMed ID: 3770066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease and drug therapy.
    Black M
    Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cardiac surgery with cardiopulmonary bypass on lidocaine disposition.
    Holley FO; Ponganis KV; Stanski DR
    Clin Pharmacol Ther; 1984 May; 35(5):617-26. PubMed ID: 6713773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of histamine-2 receptor blockade on lidocaine kinetics.
    Jackson JE; Bentley JB; Glass SJ; Fukui T; Gandolfi AJ; Plachetka JR
    Clin Pharmacol Ther; 1985 May; 37(5):544-8. PubMed ID: 3987178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy: drug disposition in old age.
    Greenblatt DJ; Sellers EM; Shader RI
    N Engl J Med; 1982 May; 306(18):1081-8. PubMed ID: 7040951
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some physiological effects caused by 30 days of bed rest in different body positions].
    Katkovskiĭ BS; Georgievskiĭ VS; Machinskiĭ GV; Mikhaĭlov VM; Pometov IuD
    Kosm Biol Aviakosm Med; 1980; 14(4):55-8. PubMed ID: 7421103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of disposition half-life, clearance, and residence times.
    Mayersohn M
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit5.3. PubMed ID: 20949436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.